News Stories

CPACT Feasibility Success with GSK


CPACT recently successfully conducted a feasibility study for GSK Consumer Health on monitoring of innovation Panadol suspension formulations. This study was part of a bigger global Process Analytical Technical program at the site where the goal is to implement a real time release control testing on multiple products.  The main objective of the program is to reduce the manufacturing cycle time by improving technical knowledge on bulk manufacture, and to reduce drastically the release lead-time and inventory so that products reach patients faster.

Paul Pilloy from GSK highlighted the following points about the benefits of the study:

  • Access to a variety of spectroscopic techniques is a real asset and to allows to rapidly select/reject options
  • Reactivity and speed to proceed with laboratory testing.
  • Treatment and interpretation of data, and presentation of results which were well introduced to GSK via detailed reports